Preclinical services news in brief

By Katrina Megget

- Last updated on GMT

Related tags Biology Dna Protein Basf

In this week's review of activity within the preclinical research
services arena, new deals have emerged involving Gene Bridges,
Panacos Pharmaceuticals, and GenScript.

Gene Bridges has signed a collaboration agreement with BASF. This will see the use of Gene Bridges' Red/ET recombination technology alongside BASF's expertise in biotechnology, process development and product application. The agreement is a significant expansion of previous service projects carried out by Gene Bridges for BASF. "We are delighted to have reached this agreement with such a major player in the industrial biotechnology sector as BASF,"​ Dr Harald Kranz, who is jointly responsible for this project, said. Meanwhile, Panacos Pharmaceuticals has extended its collaboration with Evotec into its fourth year. The programme, identifying novel compounds for treating viral infections, has expanded to now include Evotec's development chemistry services. Panacos president and chief operating officer Dr Graham Allaway said: "Based on [Evotec's] excellent track record in moving compounds through discovery and into development, we decided to broaden the scope of our work with them. We are looking forward to continuing our productive relationship." ​ In other news, international research outsourcing company GenScript has been added to VWR Biosciences's list of molecular biology partners in both proteomics and genomics. GenScript representatives believe this collaborative effort with VWB, which recommends contract research companies, will make GenScript services more accessible to scientists worldwide, with principal customers including major pharmaceutical companies, biotechnology companies, universities, clinical research entities and government institutions. GenScript, based in Piscataway, New Jersey, provides high-quality gene synthesis, custom peptides, custom proteins, custom antibodies, lab supplies, kits and reagents.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more